acut
lung
injuri
ali
sever
extrem
acut
respiratori
distress
syndrom
ard
refer
increasedperm
pulmonari
edema
caus
varieti
pulmonari
system
insult
ali
particular
ard
usual
accompani
refractori
hypoxemia
need
mechan
ventil
case
exagger
inflammatori
prothrombot
reaction
initi
stimulu
system
infect
elicit
disrupt
alveolocapillari
membran
vascular
fluid
leak
pulmonari
endothelium
major
metabol
organ
promot
adequ
pulmonari
system
vascular
homeostasi
main
target
circul
cell
humor
mediat
injuri
pulmonari
endothelium
therefor
critic
involv
pathogenesi
ali
review
discuss
mechan
pulmonari
endotheli
dysfunct
edema
gener
lung
special
emphasi
interplay
endothelium
immun
hemostat
system
highlight
principl
appli
context
defin
disord
specif
insult
implic
ali
pathogenesi
acut
lung
injuri
ali
character
hypoxem
respiratori
insuffici
noncardiogen
pulmonari
edema
caus
increas
pulmonari
vascular
permeabl
ali
sever
form
acut
respiratori
distress
syndrom
ard
compris
uniform
respons
lung
infecti
inflammatori
chemic
insult
therefor
commonli
associ
system
ill
sepsi
major
trauma
aliard
may
also
evolv
follow
pulmonari
insult
pneumonia
gastric
acid
aspir
toxic
ga
inhal
matthay
martin
ware
matthay
acuteonset
dyspnea
tachypnea
hypoxemia
cardin
clinic
featur
ali
mechan
ventil
often
requir
maintain
oxygen
ventil
patient
despit
posit
surviv
trend
note
past
two
decad
ali
patient
mortal
remain
particularli
among
elderli
patient
sepsi
prior
comorbid
avecilla
et
al
rubenfeld
et
al
even
though
rel
patient
ali
actual
die
respiratori
failur
major
appear
succumb
multipl
organ
dysfunct
mani
ali
survivor
sustain
longterm
neuropsychiatr
respiratori
impair
davidson
et
al
b
hopkin
herridg
vincent
zambon
thu
evid
syndrom
major
public
health
burden
caus
substanti
morbid
mortal
healthcar
cost
endotheli
alter
form
shift
activ
serum
level
endothelialspecif
protein
includ
angiotensin
convert
enzym
ace
tissu
factor
pathway
inhibitor
von
willebrand
factor
well
permeabl
increas
note
patient
ali
vivo
expert
consid
endotheli
cell
major
actor
host
respons
insult
relat
ali
calandrino
et
al
orfano
et
al
sabharw
et
al
ware
et
al
present
prevail
gener
concept
ali
pathogenesi
pertin
endothelium
lung
examin
concept
appli
individu
diseas
entiti
even
though
signific
portion
find
discuss
review
gener
anim
vitro
system
despit
shortcom
lab
experi
duplic
real
world
feel
mani
find
help
elucid
import
concept
relev
human
diseas
identifi
potenti
therapeut
strategi
test
patient
pulmonari
endothelium
continu
monolay
squamou
cell
intern
line
blood
vessel
togeth
collagenrich
basement
membran
separ
also
select
connect
tissu
microenviron
blood
thu
help
maintain
tissu
homeostasi
main
site
pulmonari
ga
exchang
chief
respons
lung
thin
part
alveolocapillari
membran
consist
endotheli
alveolar
epitheli
cell
individu
basement
membran
fuse
togeth
burn
et
al
weibel
arrang
facilit
diffus
gase
across
alveolocapillari
wall
allow
rapid
equilibr
blood
alveolar
oxygen
carbon
dioxid
tension
rest
exert
wagner
west
pulmonari
endothelium
particip
exchang
water
solut
blood
interstitium
normal
condit
small
amount
fluid
filter
across
endotheli
monolay
drain
lymph
fluid
filtrat
limit
continu
natur
endothelium
multipl
connect
cell
call
tight
adheren
junction
bazzoni
dejana
mehta
malik
thu
water
solut
flux
tightli
regul
occur
passiv
endotheli
cell
ec
paracellular
pathway
driven
hydrostat
pressur
gradient
intraand
perivascular
space
garcia
malik
matthay
martin
mehta
malik
albumin
macromolecul
activ
transport
cell
elabor
system
vesicl
transcellular
pathway
mehta
malik
minshal
malik
minshal
et
al
predescu
et
al
water
also
permeat
ec
via
endotheli
water
channel
call
aquaporin
agr
verkman
permeabl
properti
lung
ec
variou
anatom
locat
vari
significantli
microvascular
ec
less
permeabl
macrovascular
ec
attribut
structur
differ
interendotheli
junction
may
mechan
restrict
alveolar
flood
increas
vascular
pressur
parker
et
al
parker
yoshikawa
steven
schemat
represent
major
lung
endotheli
properti
health
given
fig
lung
ec
fulfil
import
metabol
function
substanc
bradykinin
endothelin
angiotensin
clear
blood
lung
ec
other
angiotensin
ii
nitric
oxideno
prostacyclin
produc
respons
varieti
stimuli
regul
among
other
vascular
tone
angiogenesi
cell
prolifer
barn
liu
michiel
fig
addit
pulmonari
ec
form
barrier
separ
bloodborn
humor
coagul
factor
cellular
platelet
element
coagul
thrombogen
subendotheli
tissu
endotheli
glycocalyx
complex
layer
compos
primarili
proteoglycan
glycoprotein
form
antiadhes
surfac
addit
mediat
secret
ec
cell
includ
prostacyclin
heparin
activ
protein
c
prevent
platelet
aggreg
clot
michiel
weinbaum
et
al
ec
damag
expos
basement
membran
compon
blood
thu
initi
coagul
ec
activ
regul
hemostasi
produc
prothrombot
substanc
von
willebrand
factor
pselectin
restrict
coagul
produc
antithrombot
heparan
sulfat
thrombomodulin
prostacyclin
tissu
factor
pathway
inhibitor
fibrinolyt
plasminogen
activ
factor
edelberg
et
al
final
ec
activ
involv
regul
innat
immun
system
respons
secret
inflammatori
mediat
express
molecular
machineri
allow
activ
particip
host
defenc
orfano
et
al
function
perform
lung
ec
degre
consider
heterogen
exist
lung
ec
differ
vascular
segment
bronchial
pulmonari
circul
respect
structur
function
differ
includ
cell
shape
nuclear
orient
barrier
properti
adhes
molecul
express
prolifer
rate
leukocyt
traffick
respons
intracellular
ca
increas
physic
stretch
aird
chetham
et
al
doerschuk
gebb
steven
parker
et
al
parker
yoshikawa
steven
differ
seem
reflect
presenc
anatom
function
distinct
ec
subpopul
demonstr
differenti
gene
express
surfac
marker
profil
maintain
ec
differ
vascular
segment
cell
cultur
vitro
condit
howev
influenc
local
microenviron
factor
paracrin
endocrin
signal
matrix
ec
oxygen
tension
blood
pressur
flow
also
consid
crucial
ec
phenotyp
differenti
aird
aird
garlanda
dejana
steven
inflamm
coagul
critic
host
respons
infect
injuri
involv
ali
pathogenesi
lung
endothelium
provid
surfac
integr
inflammatori
pathway
innat
immun
system
coagul
cascad
levi
et
al
clinic
observ
document
presenc
fibrin
deposit
marker
hemostasi
addit
intravascular
clot
inflammatori
marker
lung
ali
patient
fuchsbud
et
al
quinn
et
al
tomashefski
recogn
ec
orchestr
immun
hemostat
respons
shift
normal
antithrombot
antiinflammatori
phenotyp
activ
state
endotheli
dysfunct
vanhoutt
character
prothrombot
proadhes
properti
key
event
transform
express
adhes
molecul
leukocyt
platelet
ec
surfac
addit
express
activ
humor
clot
system
includ
tissu
factor
scarpati
sadler
von
willebrand
factor
sabharw
et
al
process
launch
varieti
stimuli
includ
hypoxia
cytokin
chemokin
inflammatori
mediat
activ
platelet
neutrophil
key
aspect
pulmonari
endotheli
pathobiolog
lung
injuri
illustr
fig
recent
evid
point
pivot
role
plateletneutrophil
interact
ali
platelet
rapidli
stimul
neutrophil
excret
vast
arsen
store
mediat
brandt
et
al
recent
shown
mous
model
acid
aspir
endotoxemia
process
neutrophil
activ
enhanc
bind
activ
platelet
subsequ
format
plateletneutrophil
complex
releas
inflammatori
vasoconstrict
permeabilityenhanc
prostaglandin
thromboxan
zarbock
et
al
stimul
neutrophil
transmigr
along
chemotact
gradient
lung
tissu
across
endothelium
en
rout
site
pathogen
invas
tissu
damag
due
toxic
physic
insult
contrast
system
circul
neutrophil
seem
migrat
primarili
postcapillari
venul
major
site
neutrophil
sequestr
lung
appear
alveolar
capillari
bed
burn
et
al
doerschuk
like
consequ
uniqu
pulmonari
capillari
microanatomi
sinc
mani
pulmonari
capillari
narrow
neutrophil
forc
deform
order
pass
burn
et
al
doerschuk
worthen
et
al
activ
neutrophil
undergo
cytoskelet
rearrang
render
stiff
unabl
deform
thu
trap
capillari
adher
activ
ec
neutrophil
leucocyt
lung
may
also
margin
larger
vessel
site
includ
arteriol
postcapillari
venul
ichimura
et
al
ligand
selectin
famili
compris
lselectin
express
leukocyt
eselectin
express
ec
pselectin
ec
platelet
tether
circul
leucocyt
revers
ec
surfac
facilit
roll
leucocyt
along
endothelium
point
transmigr
structur
pulmonari
microvessel
endotheli
cell
adapt
way
enabl
effici
ga
exchang
entir
cardiac
output
baselin
exert
end
permeabl
vascular
tone
kept
low
perfus
match
ventil
synthesi
releas
sever
vasoact
compound
angiotensin
ii
ii
prostacyclin
pgi
thromboxan
tx
nitric
oxid
high
vascular
complianc
lung
enabl
act
blood
reservoir
regul
coagul
thrombolysi
promot
hemofluid
number
system
aid
maintain
rapid
unobstruct
blood
flow
addit
lung
endotheli
cell
ec
metabol
highli
activ
express
enzym
angiotensin
convert
enzym
endothelin
convert
enzym
nucleotidas
synthas
lipoprotein
lipas
receptor
signal
transduct
molecul
synthes
anticoagul
hemostat
factor
import
function
lung
ec
includ
remov
biotransform
drug
particip
immun
reaction
bind
immun
complex
intern
microorgan
blood
compon
leukocyt
platelet
rbc
red
blood
cell
pmn
polymorphonuclear
granulocyt
vsmc
vascular
smooth
muscl
cell
plt
platelet
dark
blue
circl
albumin
light
blue
circl
water
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
usual
junction
three
adjac
ec
burn
et
al
pselectin
store
weibelpalad
bodi
ec
appear
surfac
follow
exposur
stimuli
bacteri
compon
ventilatorinduc
distens
acid
aspir
hypoxia
angiotensin
ii
thrombin
etc
tyrosin
kinaseand
ca
depend
manner
bhattacharya
et
al
cleator
et
al
ge
et
al
pinski
et
al
yime
et
al
zarbock
et
al
firm
adher
margin
neutrophil
ec
seem
essenti
subsequ
transmigr
import
event
neutrophilec
adher
bind
neutrophil
surfac
integrin
ec
ligand
intracellular
adhes
vascular
cell
adhes
burn
et
al
carlo
harlan
data
anim
studi
indic
type
integrin
express
neutrophil
may
vari
depend
noxiou
stimulu
exampl
e
coli
endotoxin
administr
lung
seem
induc
neutrophil
migrat
contrast
requir
neutrophil
diapedesi
model
streptococcu
pneumonia
infect
burn
et
al
doerschuk
et
al
ligat
ec
adhes
molecul
neutrophil
bind
trigger
downstream
signal
pathway
ec
induc
cytoskelet
contract
junction
open
allow
neutrophil
migrat
hordijk
signific
fraction
neutrophil
lymphocyt
migrat
across
endothelium
travers
ec
cytoplasm
engulf
larg
vesicl
vesicl
shown
caveolinposit
coat
lymphocyt
transmigr
experi
although
unknown
neutrophil
also
transport
giant
caveolar
structur
et
al
ligand
bind
adhes
molecul
also
induc
nuclear
transloc
nuclear
factor
induct
adhes
molecul
inflammationrel
gene
product
hordijk
infiltr
activ
neutrophil
releas
proteolyt
enzym
neutrophil
elastas
digest
tissu
larg
amount
oxygenbas
free
radic
bactericid
cytotox
effect
intravascular
coagul
ali
signifi
preponder
hemostat
factor
anticoagul
factor
thu
disturb
equilibrium
maintain
hemofluid
intravascular
thrombi
may
form
denud
vessel
wall
follow
ec
desquam
via
activ
intrins
pathway
may
also
form
activ
extrins
pathway
initi
tissu
factor
express
ec
cell
includ
macrophag
cytokin
induc
tissu
factor
express
tumor
necrosi
block
coagulationinhibit
fibrinolyt
pathway
initi
extrins
coagul
pathway
tissu
factor
lead
proteolyt
cleavag
prothrombin
thrombin
releas
import
downstream
effect
includ
cleavag
fibrinogen
fibrin
platelet
activ
bind
proteinaseactiv
receptor
par
thrombin
act
ec
via
receptor
evok
sever
effect
includ
ca
releas
ec
contract
permeabl
increas
coughlin
garcia
malik
ec
activ
regul
hemostasi
produc
prothrombot
substanc
von
willebrand
factor
pselectin
restrict
coagul
liber
antithrombot
heparan
sulfat
thrombomodulin
prostacyclin
tissu
factor
pathway
inhibitor
fibrinolyt
plasminogen
activ
factor
edelberg
et
al
follow
therefor
ec
play
primari
role
ali
pathogenesi
implement
crosstalk
inflammatori
clot
pathway
levi
et
al
final
ali
resolut
also
depend
preserv
ec
function
endotheli
respons
acut
lung
injuri
ec
respond
varieti
insult
convert
antiadhes
low
permeabl
barrier
adhes
high
permeabl
cell
layer
describ
detail
text
common
endotheli
insult
includ
microb
eg
bacteria
virus
protozoa
hyperoxia
radiat
immun
complex
drug
ischemia
reperfus
toxin
mechan
stretch
microemboli
adhes
molecul
surfac
ec
orchestr
transmigr
circul
immun
cell
secret
microbicid
cytotox
substanc
oxygen
free
radic
proteolyt
enzym
increas
endotheli
permeabl
vascular
tone
mediat
vasoact
substanc
includ
thrombin
angiotensin
ii
ii
thromboxan
tx
tumor
necrosi
secret
number
cell
type
ec
platelet
neutrophil
airway
epithelia
macrophag
rational
respons
seem
clearanc
infecti
agent
damag
host
cell
howev
lifethreaten
pulmonari
dysfunct
respiratori
failur
occur
consequ
lung
flood
hemodynam
compromis
alter
trigger
set
antiinflammatori
repair
process
mani
case
success
restor
vascular
integr
rbc
red
blood
cell
pmn
polymorphonuclear
granulocyt
vsmc
vascular
smooth
muscl
cell
plt
platelet
dark
blue
circl
albumin
light
blue
circl
water
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
komarova
et
al
intravascular
clot
counteract
ec
multipl
level
tissu
factor
inactiv
tissu
factor
pathway
inhibitor
upregul
thrombin
bind
thrombomodulin
endotheli
protein
c
receptor
epcr
surfac
ec
releas
activ
protein
c
apc
degrad
thrombin
elicit
cytoprotect
effect
intriguingli
par
ligat
esmon
esmon
tissu
plasminogen
activ
promot
fibrinolysi
activ
ec
also
respond
synthesi
whole
host
substanc
aim
inactiv
cytotoxin
includ
antioxid
normal
balanc
pulmonari
vasodil
vasoconstrictor
disrupt
ali
favor
latter
thu
result
increas
pulmonari
vascular
resist
pulmonari
hypertens
matthay
martin
moloney
evan
vascular
alter
ali
driven
mediat
secret
immun
cell
ec
platelet
bind
receptor
ec
vascular
smooth
muscl
cell
influenc
permeabl
vascular
tone
gene
express
mediat
thoroughli
review
sever
relat
articl
garcia
malik
kosmid
et
al
maniati
orfano
moloney
evan
orfano
et
al
includ
among
other
thrombin
oxygen
nitrogen
free
radic
superoxid
radic
prostaglandin
leukotrien
cytokin
growth
factor
transform
growth
vascular
endotheli
growth
endothelin
angiotensin
ii
precis
role
substanc
human
ali
larg
unknown
particularli
sinc
molecul
trigger
mani
differ
effect
differ
cell
type
current
understand
deriv
anim
experi
perform
less
strictli
control
condit
howev
emerg
evid
begin
shed
light
uncertainti
endotheli
synthas
eno
enzym
abundantli
express
lung
constitut
produc
larginin
oxygen
nadphdepend
fashion
dudzinski
et
al
product
stimul
ca
independ
pathway
maniati
et
al
sessa
potent
vasodil
inhibitor
hypox
pulmonari
vasoconstrict
platelet
aggreg
also
regul
gene
express
protein
function
may
regul
activ
peng
et
al
increas
level
enosderiv
correl
improv
lung
outcom
endotoxemia
ventil
injuri
ischemiareperfus
model
garrean
et
al
kaminski
et
al
kaminski
et
al
takenaka
et
al
yamashita
et
al
zhang
et
al
convers
may
deleteri
effect
hypotens
cytotox
anim
studi
seem
support
notion
highoutput
induc
synthas
ino
addit
bactericid
effect
worsen
lung
injuri
presum
direct
effect
highli
reactiv
toxic
metabolit
variou
protein
lipid
gow
et
al
prostacyclin
produc
downstream
cyclooxygenas
prostacyclin
synthas
ec
like
also
potent
vasodil
inhibitor
platelet
aggreg
act
primarili
cyclic
amp
oppos
predominantli
activ
cyclic
gmp
product
egan
fitzgerald
small
studi
children
adult
ali
aerosol
prostacyclin
improv
oxygen
dahlem
et
al
van
heerden
et
al
studi
address
mechan
action
prostacyclin
pge
ec
shown
compound
enhanc
barrier
properti
cultur
ec
baselin
attenu
thrombin
effect
confer
lung
protect
experiment
model
ventil
injuri
birukova
et
al
anoth
product
cyclooxygenas
secret
platelet
ec
thromboxan
opposit
effect
includ
platelet
aggreg
vasoconstrict
barrier
disrupt
moloney
evan
raa
potent
biolog
system
play
key
role
pulmonari
system
vascular
homeostasi
angiotensin
convert
enzym
ace
key
raa
enzym
highli
express
surfac
pulmonari
microvascular
ec
aird
ace
mainli
respons
hydrolysi
angiotensin
angiotensin
ii
breakdown
bradykinin
addit
ace
bear
distinct
outsidein
pathway
involv
cjun
ntermin
kinas
jnk
ryan
sigmund
angiotensin
ii
induc
smooth
muscl
constrict
smc
prolifer
growth
contrast
noninactiv
ace
bradykinin
exert
vasodilatori
antiinflammatori
antithrombot
action
orfano
et
al
angiotensin
ii
bear
varieti
addit
proinflammatori
action
act
via
angiotensin
receptor
stimul
express
adhes
molecul
induc
transcript
contrast
stimul
angiotensin
receptor
mainli
associ
antiinflammatori
action
decreas
increas
express
unger
stoppelhaar
accumul
inform
last
year
provid
evid
implic
raa
particular
ace
pathogenesi
acut
lung
injuri
ace
allel
associ
higher
enzym
activ
ace
insertiondelet
polymorph
appear
relat
patient
suscept
outcom
sever
aliard
studi
dd
genotyp
associ
wors
prognosi
adamzik
et
al
lee
et
al
marshal
et
al
although
aforement
associ
alway
present
villar
et
al
point
link
higher
ace
activ
sever
lung
injuri
increas
experiment
evid
suggest
raa
activ
lung
particular
angiotensin
ii
enhanc
ali
respect
yamamoto
cowork
shown
late
angiotensin
ii
induc
pulmonari
edema
rabbit
yamamoto
et
al
recent
sever
research
group
provid
evid
ace
inhibit
block
amelior
lung
injuri
induc
oleic
acid
administr
anim
exposur
vili
et
al
jerng
et
al
yao
et
al
angiotensin
ii
addit
implic
pathogenesi
fibroprolif
respons
follow
lung
injuri
effect
also
attenu
ace
inhibit
block
marshal
et
al
thu
block
deleteri
effect
angiotensin
ii
lung
might
offer
protect
ali
develop
sequela
pulmonari
endotheli
ace
ectoenzym
uniformli
distribut
along
lumin
ec
surfac
catalyt
site
expos
blood
stream
directli
access
bloodborn
substrat
activ
may
measur
vivo
mean
indicatordilut
type
techniqu
orfano
et
al
due
high
enzym
concentr
capillari
monitor
pulmonari
endotheli
ace
activ
type
studi
equal
practic
term
monitor
pulmonari
capillari
endotheliumbound
pceb
ace
activ
orfano
et
al
method
offer
quantifi
indic
may
distinguish
abnorm
secondari
endotheli
dysfunct
per
se
decreas
pulmonari
vascular
surfac
area
pcebac
activ
reduct
among
earliest
sign
differ
ali
anim
model
preced
chang
paramet
acidbas
balanc
ga
exchang
hemodynam
paramet
increas
permeabl
morpholog
chang
light
electronmicroscopi
level
case
follow
administr
bleomycin
rabbit
exposur
rabbit
hyperoxia
phorbol
myrist
acet
pma
administr
rabbit
dog
chestirradi
rabbit
orfano
et
al
ten
year
ago
similar
techniqu
introduc
human
like
anim
studi
offer
quantif
pulmonari
endotheli
function
estim
pulmonari
function
capillari
surfac
area
health
orfano
et
al
diseas
relat
latter
pcebac
activ
valid
mechan
ventil
patient
belong
high
risk
group
ard
develop
suffer
variou
degre
aliard
orfano
et
al
indic
reflect
enzym
activ
per
capillari
well
function
capillari
surfac
area
fcsa
index
max
k
decreas
earli
aliard
continuum
invers
relat
lung
injuri
score
impli
clinic
sever
syndrom
relat
degre
pcebac
activ
depress
ie
underli
pulmonari
endotheli
dysfunct
similar
respect
pcebac
activ
assess
patient
undergo
total
knee
arthroplasti
enzym
activ
depress
occur
associ
lung
injuri
induct
secondari
embol
lung
syndrom
juleselyse
et
al
addit
aforement
pcebac
activ
reduct
seen
acut
lung
vascular
patholog
enzym
activ
depress
appear
occur
chronic
lung
vasculopathi
relat
system
sclerosi
pulmonari
arteri
hypertens
langleben
et
al
orfano
et
al
fact
ace
angiotensin
ii
promot
lung
injuri
attenu
ace
inhibitor
andor
block
appear
appar
contrast
constant
well
establish
find
pcebac
activ
reduct
occur
ali
anim
human
one
possibl
explan
observ
paradox
might
follow
angiotensin
ii
gener
via
activ
nadhnadphoxidas
ec
smc
linz
et
al
superoxid
anion
interact
gener
onoo
along
free
radic
sever
sourc
caus
molecular
cellular
damag
decreas
ace
activ
possibl
observ
pcebac
activ
reduct
seen
ali
may
relat
enzym
compensatori
downregul
mediat
aforement
mechan
aim
limit
acemedi
proinflammatori
process
microenviron
would
potent
ace
activ
higher
altern
andor
addit
pcebac
reduct
may
relat
crude
endotheli
loss
viabl
ec
maintain
even
overexpress
ace
thu
contribut
local
inflammatori
process
see
radiationinduc
lung
injuri
ace
homologu
name
identifi
function
carboxypeptidas
possess
differ
substrat
specif
ace
cleav
singl
residu
angiotensin
gener
angiotensin
singl
residu
angiotensin
ii
gener
angiotensin
kuba
et
al
inform
accumul
thu
far
suggest
novel
raa
axi
counterbal
ace
angiotensin
ii
proinflammatori
action
respect
loss
express
mutant
mice
increas
lung
vascular
permeabl
edema
format
well
neutrophil
accumul
treatment
recombin
appear
improv
ali
wildtyp
knockout
mice
kuba
et
al
interest
discoveri
serv
receptor
sar
coronaviru
fact
may
trigger
dysfunct
contribut
sever
ard
sar
imai
et
al
vascular
develop
strongli
depend
collabor
growth
factor
either
produc
ec
andor
act
latter
three
differ
compound
famili
mainli
involv
process
vascular
endotheli
growth
factor
vegf
angiopoietin
ephrin
gale
yancopoulo
increas
attent
drawn
last
year
contribut
former
two
famili
pathogenesi
pathobiolog
aliard
vegf
potent
mediat
vascular
regul
angiogenesi
vascular
permeabl
water
protein
bear
central
role
growth
surviv
ec
function
vegf
gene
famili
includ
sever
member
central
best
studi
member
vegfa
also
refer
vegf
lung
vegf
act
pluripot
growth
factor
essenti
lung
develop
effici
regul
vascular
permeabl
angiogenesi
papaioann
et
al
vegf
appear
increas
microvascular
permeabl
approxim
time
potent
histamin
effect
endothelium
compris
among
other
releas
prostacyclin
inhibit
apoptosi
promot
cellsurviv
differenti
angiogenesi
vasculogenesi
lahm
et
al
hyperoxia
shown
decreas
pulmonari
vegf
level
maniscalco
et
al
vegf
mrna
express
induc
sever
stimuli
like
hypoxia
endotoxin
growth
factor
cytokin
detail
relat
analysi
reader
refer
review
lahm
et
al
papaioann
et
al
vegf
appear
contribut
complex
role
aliard
pathophysiolog
depend
diseas
stage
organ
compart
respect
decreas
level
vegf
associ
ec
apoptosi
earli
ard
abadi
et
al
differ
studi
plasma
level
found
elev
appear
associ
patient
mortal
thickett
et
al
aforement
complex
role
vegf
aliard
thoroughli
review
medford
millar
demonstr
recent
investig
recombin
vegf
administr
enhanc
alveolar
vascular
regener
hyperox
rat
pup
albeit
expens
transient
increas
permeabl
kunig
et
al
vegf
gene
therapi
addit
studi
reveal
promis
result
hyperoxiainduc
lung
injuri
newborn
rat
among
other
accompani
capillari
loss
associ
decreas
lung
vegf
express
intratrach
vegf
gene
transfer
appear
improv
surviv
promot
lung
capillari
format
thebaud
et
al
angiopoietin
ang
novel
class
angiogen
growth
factor
essenti
implic
pathophysiolog
sepsi
ali
three
identifi
famili
member
name
express
human
far
best
character
compound
receptor
agonist
induc
ec
migrat
format
capillarylik
structur
inhibit
ec
apoptosi
reduc
vascular
permeabl
inflamm
promot
vascular
integr
contrast
contextdepend
effect
act
either
agonist
antagonist
tsigko
et
al
shown
exert
inhibitori
effect
transcript
protein
level
vitro
cellbas
gene
transfer
pulmonari
circul
experiment
ard
model
markedli
reduc
lung
inflamm
confer
protect
lung
injuri
mccarter
et
al
recent
report
investig
provid
evid
syngen
mesenchym
stem
cell
transfect
human
gene
revers
lung
injuri
mice
pretreat
endotoxin
probabl
via
ecrel
mechan
similar
respect
huang
et
al
recent
shown
administr
adenovir
vector
express
murin
ali
model
protect
develop
lung
capillari
protein
leak
improv
surviv
mainli
act
modul
endotheli
barrier
disrupt
promot
vascular
leak
ali
develop
septic
surgic
criticallyil
patient
gallagh
et
al
parikh
et
al
well
hyperoxiainduc
lung
injuri
bhandari
et
al
howev
autocrin
protect
effect
activ
ec
block
vascular
leak
addit
suggest
dali
et
al
recent
investig
pattern
circul
level
criticallyil
subject
serum
level
increas
sever
sepsi
correl
serum
diseas
sever
human
lung
microvascular
ec
treat
endotoxin
respond
reduct
impli
human
pulmonari
endothelium
sourc
increas
septic
human
contrast
endotoxin
stimul
releas
bovin
lung
microvascular
ec
point
speciesspecif
differ
orfano
et
al
similar
context
gallagh
et
al
recent
report
circul
level
correl
mortal
surgic
patient
suffer
aliard
increasedperm
edema
due
disrupt
alveolocapillari
membran
alveolar
flood
proteinrich
fluid
fein
et
al
hallmark
ali
matthay
martin
earli
note
vasoact
substanc
could
induc
extravascular
fluid
leak
induc
format
gap
ec
majno
palad
lung
septic
patient
alveolar
space
contain
abund
amorph
materi
presum
extravas
plasma
protein
debri
leukocyt
erythrocyt
bachofen
et
al
ultrastructur
epitheli
cell
show
high
degre
damag
compar
ec
seem
much
less
affect
attribut
bachofen
et
al
lesser
degre
injuri
sustain
ec
potenti
cell
type
regener
later
shown
zhao
et
al
ec
endotoxem
mice
actual
possess
regen
capac
depend
upregul
transcript
factor
experi
address
mechan
endotheli
permeabl
increas
ali
focus
endotheli
respons
agonist
thrombin
histamin
bind
mediat
cellsurfac
receptor
elicit
seri
signal
event
culmin
cell
round
interendotheli
gap
format
repres
disrupt
interendotheli
junction
garcia
malik
mehta
malik
cellshap
chang
revers
case
due
initi
ec
barrierrestor
process
broman
et
al
thought
occur
ec
come
contact
inflammatori
mediat
capabl
induc
leaki
endotheli
membran
edema
format
ali
concept
actin
cytoskeleton
modul
small
gtpase
rhoa
myosin
light
chain
kinas
mlck
central
paradigm
permeabl
increas
ec
contract
garcia
garcia
malik
activ
rhoa
gproteincoupl
receptor
lutz
et
al
varieti
substanc
includ
cytokin
vasoact
molecul
thrombin
histamin
bradykinin
thromboxan
growth
factor
vegf
etc
result
actin
polymer
bundl
actin
filament
form
thicker
actin
cabl
stress
fiber
phosphoryl
myosin
light
chain
mlck
acceler
cytoskelet
contract
activ
myosin
molecular
motor
protein
bound
actin
stress
fiber
gener
forc
requir
cytoskelet
contract
dudek
garcia
support
role
mlck
sepsi
pathophysiolog
provid
studi
ex
vivo
perfus
mous
lung
use
pharmacolog
inhibitor
parker
well
vivo
mice
lack
endotheli
isoform
mlck
found
resist
ali
elicit
endotoxin
mechan
ventil
ralay
ranaivo
et
al
rossi
et
al
wainwright
et
al
endotheli
mlckdisrupt
endotoxem
septic
mice
show
reduc
activ
induc
no
express
oxid
product
increas
surviv
ralay
ranaivo
et
al
find
suggest
link
cytoskelet
process
inflammatori
mediat
product
altern
direct
role
mlck
regul
endotheli
respons
sepsi
addit
permeabl
increas
describ
cultur
cell
studi
petrach
et
al
involv
mlck
sepsi
solidifi
detect
genet
polymorph
human
respect
polymorph
mylk
gene
encod
smooth
muscl
nonsmooth
muscl
mlck
found
associ
sepsi
ali
mechan
barrier
breakdown
involv
action
mlck
also
describ
case
induc
junction
instabl
srcfamili
tyrosin
kinasemedi
phosphoryl
junction
protein
vascular
endotheli
cadherin
independ
mlck
activ
actin
stress
fiber
format
angelini
et
al
petrach
et
al
endotoxin
lipopolysaccharid
compon
outer
membran
gramneg
bacteria
induc
exagger
host
immun
reaction
endotoxin
key
mediat
gramneg
sepsi
syndrom
level
endotoxin
correl
sepsi
outcom
brandtzaeg
et
al
extracorpor
adsorpt
treatment
aim
remov
endotoxin
circul
septic
patient
present
undergo
clinic
test
cruz
et
al
endotheli
cell
directli
stimul
endotoxin
bind
tolllik
activ
transcript
number
mostli
gene
regul
inflamm
apoptosi
bannerman
goldblum
zhao
et
al
system
endotoxin
administr
caus
ali
anim
associ
neutrophil
margin
lung
endotheli
oppos
express
hematopoiet
cell
appear
critic
process
andonegui
et
al
whether
lung
injuri
direct
effect
endotoxin
action
ec
consequ
margin
stimul
neutrophil
entir
clear
howev
avail
evid
point
synerg
two
cell
type
seem
pulmonari
edema
gramneg
sepsi
may
composit
action
endotoxin
immun
cell
humor
mediat
lung
ec
endotoxin
stimul
cultur
pulmonari
endothelia
variou
speci
among
other
induc
gene
transcript
cytokin
releas
adhes
molecul
express
apoptosi
actin
cytoskelet
rearrang
activ
endocytosi
bannerman
goldblum
heckel
et
al
tiruppathi
et
al
zhao
et
al
infus
endotoxin
perfus
lung
induc
chang
held
uhlig
uhlig
et
al
rel
mild
vasoconstrict
increas
microvascular
permeabl
depend
speci
dose
salzer
mccall
urbain
et
al
walmrath
et
al
studi
though
document
endotoxin
pretreat
potenti
effect
vasoact
substanc
exotoxin
salzer
mccall
urbain
et
al
walmrath
et
al
sinc
endotoxin
trigger
endotheli
releas
molecul
capabl
alter
permeabl
vascular
pressur
intact
lung
system
includ
thromboxan
argu
vasoact
effect
like
due
mediat
due
direct
signal
held
uhlig
horgan
et
al
salzer
mccall
schmeck
et
al
urbain
et
al
signific
data
understand
ali
pathogenesi
endotoxin
vivo
endotoxin
alon
enough
caus
ali
inflammatori
respons
also
requir
larg
number
studi
address
issu
focus
pathogenet
role
neutrophil
process
although
role
immun
cell
also
begin
emerg
odea
et
al
despit
clear
evid
ali
occur
neutropen
patient
sepsi
lauf
et
al
ogniben
et
al
major
publish
literatur
seem
favor
central
role
neutrophil
import
effector
cell
induc
alveolocapillari
barrier
disrupt
ali
abraham
context
anim
experi
shown
interfer
neutrophil
function
variou
level
rang
total
neutrophil
deplet
disrupt
surfac
integrin
oxid
product
associ
blunt
lung
vascular
permeabl
increas
gao
et
al
xu
et
al
tamper
neutrophil
function
come
price
howev
sever
impair
host
defenc
result
reduc
bacteri
clearanc
ong
et
al
sadikot
et
al
interfer
neutrophil
function
might
riski
enterpris
interven
hemostat
mechan
order
answer
question
one
would
need
review
evid
role
clot
septic
ali
studi
mice
document
import
clot
factor
ali
develop
secondari
endotoxin
cruztopet
et
al
xu
et
al
relev
plateletderiv
mediat
activ
neutrophil
coagul
also
demonstr
clark
et
al
voelkel
et
al
larg
clinic
trial
util
approach
conduct
past
ten
year
trial
studi
antithrombin
iii
administr
effort
target
thrombin
central
mediat
septic
process
warren
et
al
tissu
factor
inhibitor
administr
effort
block
relat
pathway
abraham
et
al
reveal
mortal
benefit
contrast
apc
administr
improv
patient
outcom
bernard
et
al
treatment
apc
promis
number
anim
studi
use
reli
solid
scientif
background
mosnier
et
al
apc
appear
play
major
role
sepsi
import
regul
coagul
system
anticoagul
protein
c
pathway
addit
numer
investig
provid
evid
apc
exert
direct
cytoprotect
effect
variou
cell
type
specif
ec
cytoprotect
effect
appear
mostli
relat
modul
gene
express
antiinflammatori
antiapoptot
activ
ec
barrier
stabil
mosnier
et
al
orfano
et
al
cytoprotect
effect
requir
activ
proteas
activ
endotheli
protein
c
receptor
epcr
serv
coreceptor
anim
studi
us
other
use
apc
inhal
document
lungprotect
effect
drug
kotanid
et
al
slofstra
et
al
despit
appar
variat
mode
apc
action
probabl
relat
differ
experiment
design
apc
administr
patient
sever
sepsi
one
promis
discuss
topic
critic
care
set
human
trial
apc
efficaci
reduc
mortal
sever
sepsi
benefici
action
appear
restrict
sever
affect
patient
et
al
recent
guidelin
surviv
sepsi
campaign
use
apc
adult
given
grade
recommend
delling
et
al
indic
lack
clariti
regard
riskbenefit
ratio
european
union
mandat
issu
address
placebocontrol
clinic
trial
interestingli
pediatr
patient
appear
benefit
apc
administr
use
clearli
discourag
group
delling
et
al
fact
intervent
seem
work
laboratori
appear
less
efficaci
clinic
set
probabl
interpret
failur
experiment
studi
deliv
valid
diseas
concept
rather
repres
discrep
simpl
anim
model
sepsi
use
basic
research
shortcom
reflect
complex
clinic
situat
attempt
come
summari
statement
role
pulmonari
endothelium
endotoxemia
seem
endotoxin
induct
mediat
prime
ec
attract
captur
activ
immun
cell
act
concert
platelet
coagul
factor
mount
inflammatori
respons
accompani
sepsisderiv
ali
mechan
ventil
respiratori
failur
critic
mode
life
support
mani
aliard
patient
graviti
forc
distribut
pulmonari
edema
ali
depend
area
result
lowcompli
poorli
ventil
region
higher
complianc
region
receiv
bulk
ga
volum
deliv
ventil
gattinoni
et
al
gattinoni
pesenti
add
insult
injuri
increas
ventil
requir
mani
patient
order
maintain
adequ
oxygen
face
larg
physiolog
dead
space
effect
elimin
excess
co
produc
activ
state
metabol
thu
physician
end
forc
excess
ventil
lung
limit
airspac
avail
ga
exchang
caus
tissu
overdistent
injuri
lead
form
ali
term
ventilatorinduc
lung
injuri
vili
gattinoni
et
al
gattinoni
pesenti
demonstr
anim
human
studi
vili
exacerb
preexist
ali
caus
system
inflamm
remot
organ
dysfunct
increas
mortal
do
santo
slutski
petrucci
iacovelli
acut
respiratori
distress
syndrom
network
ec
contractil
cell
possess
structur
sens
mechan
forc
translat
biochem
signal
event
mechanotransduct
due
coupl
alveolar
cell
ec
expos
stretch
mechan
ventil
elicit
larg
number
ec
biochem
structur
alter
research
therefor
engag
question
key
signal
pathway
govern
cellular
respons
vili
would
happen
ec
prevent
respond
stretch
question
particularli
import
set
vili
contrast
aliard
vili
repres
iatrogen
entiti
known
tempor
onset
could
prevent
intervent
target
initi
signal
pathway
data
cultur
pulmonari
ec
isol
intact
lung
consist
demonstr
increas
tyrosin
phosphoryl
lead
pselectindepend
neutrophil
margin
bhattacharya
et
al
ichimura
et
al
shikata
et
al
yime
et
al
src
nonreceptor
tyrosin
kinas
shown
implic
event
well
enhanc
microvascular
permeabl
direct
action
ec
miyahara
et
al
okutani
et
al
studi
address
effect
endotheli
ca
influx
clarifi
signific
transient
receptor
potenti
ca
channel
acut
permeabl
alter
due
overdistent
hamanaka
et
al
townsley
et
al
addit
excess
cyclic
stretch
elong
induc
actin
stress
fiber
format
due
rhoadepend
mlck
activ
cultur
human
pulmonari
arteri
ec
birukov
et
al
cell
stretch
protocol
h
subsequ
challeng
thrombin
respond
greater
permeabl
increas
cell
physiolog
stretch
elong
birukov
et
al
birukova
et
al
work
use
isol
rat
lung
expos
ventil
overdistent
show
mlck
inhibit
prevent
permeabl
increas
parker
final
mix
model
endotoxin
vili
demonstr
mice
lack
ec
mlck
improv
outcom
wildtyp
control
ralay
ranaivo
et
al
rossi
et
al
studi
elucid
mechanist
direct
effect
cyclic
stretch
ec
acut
permeabl
alter
like
subsequ
event
includ
activ
inflammatori
gene
express
held
et
al
thu
provid
import
target
pharmacolog
intervent
could
clinic
use
transfus
red
blood
cell
concentr
rbc
blood
product
common
practic
intens
care
unit
patient
due
anemia
critic
ill
blood
loss
transfus
elicit
ali
small
subset
patient
transfusionrel
acut
lung
injuri
trali
common
caus
death
relat
transfus
hol
et
al
silliman
trali
otherwis
clinic
patholog
indistinguish
ali
occur
almost
immedi
within
h
mostli
first
h
silliman
et
al
follow
transfus
variou
blood
product
includ
rbc
fresh
frozen
plasma
hol
et
al
identif
donor
antibodi
human
leukocyt
antigen
popovski
et
al
recipi
spawn
hypothesi
trali
mediat
immun
reaction
curti
mcfarland
sach
silliman
silliman
et
al
studi
plasma
donat
blood
reveal
presenc
mainli
three
type
antibodi
possibl
implic
trali
includ
antibodi
hlai
hlaii
human
neutrophil
antigen
hna
class
neutrophil
surfac
marker
poorli
understood
function
curti
mcfarland
neutrophil
appear
import
effector
cell
process
dri
et
al
silliman
et
al
cell
cultur
anim
studi
use
model
trali
detect
releas
inflammatori
mediat
cytokin
neutrophil
incrimin
pathogenesi
syndrom
grimming
et
al
wyman
et
al
activ
neutrophil
antihla
antibodi
induc
endotheli
adhes
molecul
express
cell
death
cultur
ec
nishimura
et
al
silliman
et
al
permeabl
increas
perfus
intact
microvessel
seeger
et
al
mechan
neutrophil
activ
howev
well
understood
sinc
mani
patient
receiv
transfus
antibodi
white
blood
cell
develop
trali
postul
prior
neutrophil
activ
adhes
lung
ec
set
sepsi
inflammatori
condit
necessari
trali
develop
silliman
one
largest
clinic
case
seri
publish
gajic
et
al
show
transfus
patient
sepsi
histori
alcohol
use
like
develop
trali
gajic
et
al
addit
studi
trali
often
observ
transfus
blood
product
multipar
women
like
harbour
antineutrophil
antibodi
due
immun
fatal
blood
provid
indirect
support
role
antibodi
trali
mediat
howev
case
trali
attribut
antibodi
sinc
syndrom
seen
transfus
product
contain
antibodi
autolog
blood
covin
et
al
observ
led
identif
anoth
caus
trali
name
bioactiv
lipid
silliman
et
al
silliman
et
al
lysophosphatidylcholin
phospholipid
releas
store
blood
compon
includ
rbc
platelet
bind
cellsurfac
receptor
neutrophil
activ
oxid
releas
nadphoxidas
ca
depend
mechan
silliman
et
al
prospect
observ
studi
bioactiv
lipid
account
major
trali
case
silliman
et
al
seem
therefor
trali
uncommon
seriou
complic
transfus
lead
neutrophilmedi
ec
toxic
increas
pulmonari
microvascular
permeabl
embol
arteri
diamet
less
caus
revers
increas
pulmonari
microvascular
permeabl
malik
explain
combin
factor
act
ec
includ
releas
vasoact
ec
mediat
clot
system
thrombin
inflammatori
cell
malik
degre
lung
dysfunct
depend
amount
natur
embol
materi
exampl
embol
tumor
cell
known
caus
edema
oppos
amniot
fluid
contain
antigen
fetal
substanc
often
lead
respiratori
failur
pathophysiolog
concept
may
relev
varieti
diseas
process
sickl
cell
crisi
fat
embol
fractur
bone
fatcontain
intern
organ
embol
amniot
fluid
ga
silicon
cement
use
surgic
endovascular
procedur
although
case
pathomechan
remain
incomplet
understood
bari
malik
fabian
fukaya
hopf
mirski
et
al
moor
baldisseri
schmid
et
al
follow
section
briefli
discuss
salient
featur
sickl
cell
acut
chest
syndrom
acut
chest
syndrom
devast
rel
common
complic
sickl
cell
diseas
relat
hemoglobinopathi
hemoglobin
hb
ss
hb
sc
hb
sthalassemia
melton
hayn
usual
occur
vasooccluss
episod
lung
microvessel
occlud
adher
sickl
cell
white
blood
cell
emboli
infarct
bone
marrow
obstruct
pulmonari
microvessel
maitr
et
al
melton
hayn
vichinski
et
al
event
complic
state
preexist
endotheli
dysfunct
sickl
cell
patient
character
increas
oxid
product
hemoglobin
membran
lipid
peroxid
decreas
bioavail
increas
secret
adhes
brown
et
al
nath
et
al
phelan
et
al
pritchard
et
al
shiu
et
al
telen
numer
public
last
year
along
clinic
experi
accumul
human
undergo
lung
transplant
resuscit
hemorrhag
shock
hs
reveal
impact
ischemiareperfus
ir
lung
ali
postir
mainli
associ
format
reactiv
oxygen
nitrogen
speci
hamva
et
al
ischiropoulo
et
al
well
leukocyt
interact
activ
pulmonari
endothelium
martinezmi
et
al
lung
may
addit
target
proinflammatori
mediat
releas
distal
ir
respect
mesenter
ir
rat
impair
pulmonari
endothelialdepend
vasorelax
induc
increas
neutrophil
lung
accumul
fullerton
et
al
recent
public
boutro
et
al
shown
ir
lower
extrem
rat
associ
lung
injuri
character
neutrophil
infiltr
increas
vascular
permeabl
ali
model
accompani
increas
pulmonari
express
induc
hemeoxygenas
inhibit
latter
enhanc
ali
boutro
et
al
harm
ir
effect
endothelium
reveal
observ
shed
endotheli
glycocalyx
patient
undergo
surgic
procedur
involv
global
ischemia
region
ischemia
heart
lung
procedur
induc
signific
increas
endotheli
glycocalyx
compon
heparin
sulfat
blood
rehm
et
al
sever
investig
focus
effect
ir
relat
intervent
pulmonari
endotheliumbound
ace
atochina
cowork
provid
evid
normox
lung
ir
induc
ace
shed
pulmonari
endothelium
isol
perfus
rat
lung
event
associ
increas
lung
vascular
permeabl
atochina
et
al
shed
pulmonari
endotheli
ace
follow
ir
similar
anim
model
appear
attenu
anesthet
agent
propofol
also
carri
antioxid
properti
balyasnikova
et
al
preliminari
recent
report
provid
evid
normoxem
resuscit
hs
rabbit
associ
decreas
pcebac
activ
phenomenon
associ
higher
lung
express
resuscit
hypox
mixtur
preserv
endotheli
enzym
activ
attenu
lung
inflamm
orfano
et
al
addit
import
role
pulmonari
endotheliumbound
ace
ir
lung
injuri
recent
shown
nowak
cowork
conjug
antioxid
enzym
catalas
antiac
antibodi
allow
lung
endothelium
target
attenu
lung
injuri
rat
ir
model
nowak
et
al
resuscit
hs
major
global
ir
phenomenon
frequent
met
clinic
emerg
set
lung
among
principl
organ
affect
central
role
cell
adhes
molecul
ir
pathophysiolog
lead
enhanc
leukocyteendotheli
interact
inflamm
promot
well
establish
martinezmi
et
al
interestingli
numer
report
provid
evid
benefici
effect
sever
fluid
resuscit
regimen
use
specif
effect
leukocyt
endotheli
adhes
molecul
lung
tissu
respect
resuscit
hs
hyperton
salin
mice
shown
diminish
neutrophil
roll
adher
endothelium
vivo
alter
ecpmn
interact
diminish
vascular
permeabl
pascual
et
al
thorough
analysi
field
beyond
scope
review
reader
refer
martinezmi
et
al
pulmonari
tissu
exhibit
high
sensit
ioniz
radiat
effect
limit
use
actinotherapi
lung
thoraxrel
tissu
exposur
chest
ioniz
radiat
produc
dosedepend
acut
injuri
affect
endotheli
epitheli
interstiti
cell
type
endotheli
cell
appear
among
first
cell
type
undergo
function
structur
injuri
initi
acut
radiat
pneumon
occur
character
bronchoalveolar
endotheli
swell
associ
increas
capillari
permeabl
interstiti
intraalveolar
edema
accumul
inflammatori
cell
fibrosi
sever
patient
either
undergon
radiat
pneumon
develop
develop
acut
reaction
develop
lung
fibrosi
later
stage
epperli
et
al
accumul
research
provid
evid
ioniz
radiat
affect
express
variou
proinflammatori
growthinduc
gene
control
product
transform
growth
factorbeta
fibroblast
growth
factor
transcript
giaid
et
al
pulmonari
radiat
mice
appear
induc
express
adhes
molecul
initi
detect
endothelinposit
ec
phenomena
associ
late
develop
lung
fibrosi
delay
administr
manganes
superoxid
dismutaseplasmidliposom
suggest
pulmonari
endothelium
may
potenti
target
intervent
fibrosi
epperli
et
al
similar
respect
radiat
induc
persist
pulmonari
endotheli
upregul
event
probabl
lead
sustain
plateletec
adhes
thrombosi
gaugler
et
al
increas
format
inossynthes
nitrotyrosin
occur
irradi
lung
mous
model
giaid
et
al
pulmonari
endotheli
ectoenzym
activ
measur
shown
provid
earli
sensit
indic
radiationinduc
endotheli
lung
injuri
respect
rabbit
expos
gy
ioniz
radiat
produc
earli
decreas
pcebac
affin
substrat
vivo
absenc
structur
endotheli
damag
catrava
et
al
aforement
earli
dysfunct
pulmonari
endotheli
ectoenzym
confirm
broad
rang
pulmonari
blood
flow
rabbit
heartbypass
model
ie
hemodynam
independ
anim
treatment
indomethacin
appear
prevent
alter
impli
probabl
role
arachidon
acid
metabolit
orfano
et
al
sever
investig
report
pulmonari
unilater
bilater
ace
decreas
postirradi
plasma
ace
level
measur
either
preor
duringradiotherapi
lung
found
lower
patient
develop
radiat
pneumon
ward
et
al
zhao
et
al
appar
contrast
abovement
inform
agreement
previous
analyz
ace
paradox
treatment
radiat
rat
novel
angiotensin
ii
blocker
ace
inhibitor
captopril
enalapril
protect
lung
radiationinduc
pneumon
fibrosi
interf
pathway
evolv
alphaactomyosin
molteni
et
al
ace
paradox
set
radiationinduc
lung
endotheli
injuri
might
least
partli
explain
find
papapetropoulo
cowork
exposur
bovin
pulmonari
arteri
endotheli
cell
radiat
result
decreas
viabl
ec
lead
subsequ
decreas
ace
activ
per
cultur
well
contrast
ace
activ
per
surviv
ec
increas
timeand
radiationdos
manner
papapetropoulo
et
al
therefor
probabl
observ
ace
activ
reduct
relat
ec
loss
increas
enzym
activ
surviv
cell
may
promot
inflamm
cell
prolifer
paracrin
pattern
phenomena
attenu
administr
ace
inhibitor
andor
angiotensin
ii
receptor
antagonist
acut
lung
injuri
acut
respiratori
distress
syndrom
umbrella
term
describ
increas
endotheli
permeabilityinduc
pulmonari
edema
respiratori
insuffici
varieti
clinic
circumst
endotheli
cell
central
pathogenesi
ali
research
far
success
provid
basic
understand
diseas
mechan
led
signific
improv
treatment
ali
notabl
regard
proper
way
ventil
resuscit
patient
still
sever
import
aspect
remain
unclear
especi
field
lung
repair
process
import
hurdl
research
difficulti
design
experi
reflect
complex
critic
ill
laboratori
studi
defin
stimulu
appli
rel
shortterm
experi
outcom
measur
howev
clinic
practic
sever
factor
could
predispos
patient
ali
time
mean
mani
redund
pathway
studi
individu
lab
would
concomitantli
activ
reallif
patient
exampl
patient
polytrauma
may
develop
lung
injuri
due
fat
embol
blood
transfus
healthcareassoci
infect
patient
abdomin
sepsi
may
develop
lung
injuri
due
endotoxin
ventil
stretch
ventilatorassoci
pneumonia
toxic
due
oxygenrich
ga
mixtur
nevertheless
understand
pathomechan
advanc
like
develop
therapeut
modal
protect
lung
critic
ill
demonstr
experiment
endotheli
target
treatment
christofidousolomid
et
al
nowak
et
al
progress
imper
order
deal
still
high
mortal
morbid
associ
condit
